Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ('Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces positive new ...

Excerpted with permission from the publisher The Emperor of All Maladies: A Biography of Cancer (Revised Edition, 2026), Siddhartha Mukherjee, published by Fourth Estate, HarperCollins India.

Severe infections requiring hospitalization are associated with a markedly increased long-term IBD risk, with immune-related ...

What does it say when a national insurer chooses to follow the science before being forced to by law? This year, Aetna updated its coverage policy to recognize Pediatric Acute-onset Neuropsychiatric ...

A woman who endured a decade of debilitating menstrual pain and irregular periods has revealed how doctors repeatedly ...

A father is facing certain death unless he hits an ambitious fundraising target for a liver transplant - after the NHS ruled him ineligible for a life-saving op.

Researchers from Brown University and the University of Rochester will lead a multi-institution project to test whether ...

Grafting materials, lasers, and low frequency vibration speed up healing The use of grafting materials, laser therapy, ...

The chronic autoimmune conditions — both considered types of inflammatory bowel disease — cause a myriad of symptoms ...

Theriva received a $300,000 upfront payment at signing and is eligible for up to $38M in development, regulatory, and sales ...

GLP-1 receptor agonists improve glycemic control and weight while reducing cardiovascular events, with tolerability limited by gastrointestinal adverse effects requiring gradual dose escalation.

Crohn's disease is associated with several eye conditions. Here's what you need to know to protect your vision.